Lilly pursue Cialis over-the-counter approval
Send a link to a friend
[May 28, 2014]
PARIS (Reuters) - Sanofi
and Eli Lilly and Co have agreed to pursue regulatory
approval for over-the-counter sales of erectile
dysfunction treatment Cialis, the French and U.S.
drugmakers said in a statement on Wednesday.
Cialis is currently available by prescription only, and was first
approved by the European Medicines Agency in 2002 and then by the
U.S. Food and Drug Administration in 2003. It generated $2.16
billion in worldwide sales in 2013 and has recorded total sales of
more than $14 billion since launch.
Under the terms of the agreement, Sanofi is buying the exclusive
rights to apply for approval of Cialis tablets over the counter in
the United States, Europe, Canada and Australia. Terms of the
licensing agreement were not disclosed.
(Reporting by James Regan; Editing by Mark Potter)
[to top of second column]
[© 2014 Thomson Reuters. All rights
Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.